Weighted Average Number of Shares Outstanding, Diluted of TuHURA Biosciences, Inc./NV from 30 Sep 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
TuHURA Biosciences, Inc./NV quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Sep 2012 to 30 Sep 2025.
  • TuHURA Biosciences, Inc./NV Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 50,666,430, a 316% increase year-over-year.
  • TuHURA Biosciences, Inc./NV annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 18,662,690, a 57% increase from 2023.
  • TuHURA Biosciences, Inc./NV annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 11,889,193.
  • TuHURA Biosciences, Inc./NV annual Weighted Average Number of Shares Outstanding, Diluted for 2015 was 38,067,516, a 2.6% decline from 2014.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

TuHURA Biosciences, Inc./NV Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 50,666,430 +38,487,908 +316% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 44,555,095 +32,376,573 +266% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 43,404,947 +31,231,215 +257% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 18,662,690 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 12,178,522 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 12,178,522 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 12,173,732 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q2 2015 38,067,516 -1,022,815 -2.6% 01 Apr 2015 30 Jun 2015 10-K 16 Nov 2015 2015 FY
Q1 2015 38,976,827 +7,317,036 +23% 01 Jan 2015 31 Mar 2015 10-Q 15 May 2015 2015 Q3
Q4 2014 37,798,183 +6,274,451 +20% 01 Oct 2014 31 Dec 2014 10-Q 12 Feb 2015 2015 Q2
Q3 2014 36,451,014 -5,220,775 -13% 01 Jul 2014 30 Sep 2014 10-Q 07 Nov 2014 2015 Q1
Q2 2014 39,090,331 01 Apr 2014 30 Jun 2014 10-K 16 Nov 2015 2015 FY
Q1 2014 31,659,791 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q3
Q4 2013 31,523,732 01 Oct 2013 31 Dec 2013 10-Q 12 Feb 2015 2015 Q2
Q3 2013 41,671,789 +28,702,006 +221% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014 2015 Q1
Q3 2012 12,969,783 01 Jul 2012 30 Sep 2012 10-Q 08 Nov 2013 2013 Q3

TuHURA Biosciences, Inc./NV Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 18,662,690 +6,773,497 +57% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 11,889,193 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2015 38,067,516 -1,022,815 -2.6% 01 Jul 2014 30 Jun 2015 10-K 16 Nov 2015 2015 FY
2014 39,090,331 01 Jul 2013 30 Jun 2014 10-K 16 Nov 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.